Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.35p
   
  • Change Today:
      0.050p
  • 52 Week High: 14.13p
  • 52 Week Low: 3.30p
  • Currency: UK Pounds
  • Shares Issued: 132.35m
  • Volume: 164,059
  • Market Cap: £4.43m
  • RiskGrade: 435

Regulatory News

Agreement to License VAL401 to Ambrose Healthcare 05-Dec-2023 07:00 RNS
Evaluation Agreement with StingRay Bio 10-Nov-2023 07:00 RNS
Statement re Share Price Movement 06-Oct-2023 10:45 RNS
Operational Review 28-Sep-2023 07:00 RNS
Half-year Report 24-Aug-2023 07:00 RNS
Collaborative Services Agreement 14-Aug-2023 07:00 RNS
Result of AGM 28-Jun-2023 14:15 RNS
Conclusion of Hokkaido Evaluation Agreement 16-Jun-2023 07:00 RNS
Asset Purchase – Imagen Therapeutics 14-Jun-2023 07:00 RNS
Update on proposed sub-license of VAL201 08-Jun-2023 07:00 RNS
Expanded agreement with University of Barcelona 07-Jun-2023 07:00 RNS
Final Results and Notice of AGM 05-Jun-2023 07:00 RNS
Notice of Results and Investor Webinar 26-May-2023 07:00 RNS
Collaborative Services Agreement 26-Apr-2023 07:00 RNS
Quarterly Operational Update 31-Mar-2023 07:00 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Valirx Market Data

Currency UK Pounds
Share Price 3.35p
Change Today 0.050p
% Change 1.52 %
52 Week High 14.13p
52 Week Low 3.30p
Volume 164,059
Shares Issued 132.35m
Market Cap £4.43m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
19.74% below the market average19.74% below the market average19.74% below the market average19.74% below the market average19.74% below the market average
13.73% above the sector average13.73% above the sector average13.73% above the sector average13.73% above the sector average13.73% above the sector average
Price Trend
94.03% below the market average94.03% below the market average94.03% below the market average94.03% below the market average94.03% below the market average
82.14% below the sector average82.14% below the sector average82.14% below the sector average82.14% below the sector average82.14% below the sector average
Income Not Available
Growth Not Available

Valirx Dividends

No dividends found

Trades for 26-Apr-2024

Time Volume / Share Price
16:25 22,500 @ 3.35p
16:13 70,000 @ 3.33p
16:00 45 @ 3.40p
15:53 12,500 @ 3.40p
15:18 56,047 @ 3.39p

Valirx Key Personnel

CFO Gerald Desler
CEO Suzanne Dilly

Top of Page